117 related articles for article (PubMed ID: 38689449)
1. Bilateral Adrenal Metastasis of Prostatic Adenocarcinoma on 68Ga-PSMA PET/CT Imaging.
Beyhan E; Turan Bektaş C; Baloğlu MC; Tosunoğlu Z; Çermik TF
Clin Nucl Med; 2024 May; ():. PubMed ID: 38689449
[TBL] [Abstract][Full Text] [Related]
2. 68Ga-PSMA-11 PET/CT in Isolated Bilateral Adrenal Metastases From Prostate Adenocarcinoma.
Zhao Q; Yang B; Dong A; Zuo C
Clin Nucl Med; 2022 Jan; 47(1):e101-e102. PubMed ID: 34115707
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.
Keidar Z; Gill R; Goshen E; Israel O; Davidson T; Morgulis M; Pirmisashvili N; Ben-Haim S
Cancer Imaging; 2018 Nov; 18(1):39. PubMed ID: 30382889
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy.
Kesler M; Druckmann I; Levine C; Kuten J; Yossepowitch O; Even-Sapir E
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33578990
[TBL] [Abstract][Full Text] [Related]
7. The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.
Eissa A; Elsherbiny A; Coelho RF; Rassweiler J; Davis JW; Porpiglia F; Patel VR; Prandini N; Micali S; Sighinolfi MC; Puliatti S; Rocco B; Bianchi G
Minerva Urol Nefrol; 2018 Oct; 70(5):462-478. PubMed ID: 29664244
[TBL] [Abstract][Full Text] [Related]
8. Enhancing PSMA-uptake with androgen deprivation therapy - a new way to detect prostate cancer metastases?
Leitsmann C; Thelen P; Schmid M; Meller J; Sahlmann CO; Meller B; Trojan L; Strauss A
Int Braz J Urol; 2019; 45(3):459-467. PubMed ID: 30901173
[TBL] [Abstract][Full Text] [Related]
9. A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa.
Schmidt-Hegemann NS; Zamboglou C; Thamm R; Eze C; Kirste S; Spohn S; Li M; Stief C; Bolenz C; Schultze-Seemann W; Bartenstein P; Prasad V; Ganswindt U; Grosu AL; Belka C; Mayer B; Wiegel T
Front Oncol; 2021; 11():723536. PubMed ID: 34660290
[TBL] [Abstract][Full Text] [Related]
10. The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy.
Gultekin MH; Demirci E; Turegun FA; Kabasakal L; Sahin OE; Ocak M; Onal B; Erozenci A
Urol J; 2020 Dec; 18(1):58-65. PubMed ID: 33349912
[TBL] [Abstract][Full Text] [Related]
11. Isolated Castrate-resistant Prostate Cancer Metastasis to Both Adrenal Glands Detected on
Kanatsız O; Özülker F; Aydın T; Özülker T
Mol Imaging Radionucl Ther; 2023 Oct; 32(3):244-246. PubMed ID: 37870375
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-PSMA-11 PET/CT in a Case of Isolated Parietal Peritoneal Metastasis From Prostate Adenocarcinoma.
Zhao Q; Dong A; Zuo C
Clin Nucl Med; 2023 Oct; 48(10):913-914. PubMed ID: 37682611
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F
Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574
[TBL] [Abstract][Full Text] [Related]
15. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan.
Zhao R; Li Y; Nie L; Qin K; Zhang H; Shi H
Medicine (Baltimore); 2021 Apr; 100(15):e25417. PubMed ID: 33847640
[TBL] [Abstract][Full Text] [Related]
16. A prospective intra-individual comparison of [
Lawal IO; Mokoala KMG; Mahapane J; Kleyhans J; Meckel M; Vorster M; Ebenhan T; Rösch F; Sathekge MM
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):134-142. PubMed ID: 32424485
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
Singh B; Sharma S; Bansal P; Hooda M; Singh H; Parihar AS; Kumar A; Watts A; Mohan R; Singh SK
Nucl Med Commun; 2021 May; 42(5):482-489. PubMed ID: 33395191
[TBL] [Abstract][Full Text] [Related]
18. Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
Stanzel S; Weitzer F; Janek E; Plhak E; Aigner RM
Clin Nucl Med; 2023 Dec; 48(12):1064-1065. PubMed ID: 37934704
[TBL] [Abstract][Full Text] [Related]
19. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
Kesim S; Oksuzoglu K
Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
[TBL] [Abstract][Full Text] [Related]
20. De Novo Metastatic Prostate Cancer Presenting With Atypical Lower-Limb Skeletal Metastases Detected on 68Ga-PSMA PET/CT.
Yip A; Yap J
Clin Nucl Med; 2024 Apr; ():. PubMed ID: 38687004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
